News from May 2009

Medu Capital finds appetite in healthcare

Medu Capital finds appetite in healthcare thumbnail

Private equity — traditionally wary of the complex, highly regulated drugs sector — is increasingly scanning the pharmaceuticals industry for value, suggesting scope for sizeable buyouts. PRIVATE equity fund Medu Capital has acquired for an undisclosed sum a 40% equity interest in Medipost Courier Pharmacy and a 40% stake in medical distribution firm Kawari Wholesaler.
Other [...]


Medu Capital takes up a 40% equity stake in Medipost Courier Pharmacy

Medu Capital takes up a 40% equity stake in Medipost Courier Pharmacy thumbnail

Medipost was established in 1991 as the first courier pharmacy in South Africa, with a focus on the distribution of chronic medication to patients nationally. Medipost currently processes an average of 140,000 prescriptions per month, making it the largest courier pharmacy in South Africa. Kawari was established in 2004 as a pharmaceutical wholesaler which supplies medicines to various retail and courier pharmacies nationally.




LATEST NEWS HEADLINES

ALSO IN THE NEWS

SA Private Equity gains confidence thumbnail SA Private Equity gains confidence

South African private equity firms are increasingly looking at the rest of the continent, spurred by the success of local telecoms and retail companies in Africa’s frontier markets, according to KPMG.
Africa’s biggest economy accounted for more than 70 percent of the sub-Saharan region’s $2.9 billion of private equity deals in 2008, but this share is [...]

MORE STORIES

How to get a job in private equity: The ideal CV thumbnail How to get a job in private equity: The ideal CV

HAVE YOUR SAY

HAVE YOUR SAY Join our list of prestigious institutions who have contributed their expertise our site. It’s a great way to share your views and gain recognition for your insights and thought leadership.

PROMOTIONAL BLOCK - ADVERTISE

PROMOTIONAL BLOCK - ADVERTISE We have various advertising opportunities, please enquire now!

MORE NEWS HEADLINES


Switch to our mobile site